These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38227820)

  • 21. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of PEG on polymeric particles surface, a key step in drug carrier translation.
    Rabanel JM; Hildgen P; Banquy X
    J Control Release; 2014 Jul; 185():71-87. PubMed ID: 24768790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(l-glutamic acid)-g-poly(ethylene glycol) external layer in polyelectrolyte multilayer films: Characterization and resistance to serum protein adsorption.
    Szczepanowicz K; Kruk T; Świątek W; Bouzga AM; Simon CR; Warszyński P
    Colloids Surf B Biointerfaces; 2018 Jun; 166():295-302. PubMed ID: 29604572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface Charge Switchable Polymer/DNA Nanoparticles Responsive to Tumor Extracellular pH for Tumor-Triggered Enhanced Gene Delivery.
    Ooi YJ; Wen Y; Zhu J; Song X; Li J
    Biomacromolecules; 2020 Mar; 21(3):1136-1148. PubMed ID: 31944668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatings.
    Li A; Luehmann HP; Sun G; Samarajeewa S; Zou J; Zhang S; Zhang F; Welch MJ; Liu Y; Wooley KL
    ACS Nano; 2012 Oct; 6(10):8970-82. PubMed ID: 23043240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.
    Ray P; Confeld M; Borowicz P; Wang T; Mallik S; Quadir M
    Colloids Surf B Biointerfaces; 2019 Feb; 174():126-135. PubMed ID: 30447521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyglycerol Grafting Shields Nanoparticles from Protein Corona Formation to Avoid Macrophage Uptake.
    Zou Y; Ito S; Yoshino F; Suzuki Y; Zhao L; Komatsu N
    ACS Nano; 2020 Jun; 14(6):7216-7226. PubMed ID: 32379425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
    Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
    Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shedding light on surface exposition of poly(ethylene glycol) and folate targeting units on nanoparticles of poly(ε-caprolactone) diblock copolymers: Beyond a paradigm.
    Venuta A; Moret F; Dal Poggetto G; Esposito D; Fraix A; Avitabile C; Ungaro F; Malinconico M; Sortino S; Romanelli A; Laurienzo P; Reddi E; Quaglia F
    Eur J Pharm Sci; 2018 Jan; 111():177-185. PubMed ID: 28966100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo.
    Grenier P; Viana IMO; Lima EM; Bertrand N
    J Control Release; 2018 Oct; 287():121-131. PubMed ID: 30138715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles.
    Wang JL; Du XJ; Yang JX; Shen S; Li HJ; Luo YL; Iqbal S; Xu CF; Ye XD; Cao J; Wang J
    Biomaterials; 2018 Nov; 182():104-113. PubMed ID: 30114562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced uptake in 2D- and 3D- lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra- and intracellular environments.
    Conte C; Mastrotto F; Taresco V; Tchoryk A; Quaglia F; Stolnik S; Alexander C
    J Control Release; 2018 May; 277():126-141. PubMed ID: 29534890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of highly dispersible and tumor-accumulative, iron oxide nanoparticles Multi-point anchoring of PEG-b-poly(4-vinylbenzylphosphonate) improves performance significantly.
    Ujiie K; Kanayama N; Asai K; Kishimoto M; Ohara Y; Akashi Y; Yamada K; Hashimoto S; Oda T; Ohkohchi N; Yanagihara H; Kita E; Yamaguchi M; Fujii H; Nagasaki Y
    Colloids Surf B Biointerfaces; 2011 Dec; 88(2):771-8. PubMed ID: 21890332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering Well-Characterized PEG-Coated Nanoparticles for Elucidating Biological Barriers to Drug Delivery.
    Yang Q; Lai SK
    Methods Mol Biol; 2017; 1530():125-137. PubMed ID: 28150200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facile Generation of Tumor-pH-Labile Linkage-Bridged Block Copolymers for Chemotherapeutic Delivery.
    Sun CY; Liu Y; Du JZ; Cao ZT; Xu CF; Wang J
    Angew Chem Int Ed Engl; 2016 Jan; 55(3):1010-4. PubMed ID: 26756443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the Polymer Cloak for Upconverting Nanoparticles: An Evaluation of Bioactivity and Optical Performance.
    Zhang L; Chen C; Tay SS; Wen S; Cao C; Biro M; Jin D; Stenzel MH
    ACS Appl Mater Interfaces; 2021 Apr; 13(14):16142-16154. PubMed ID: 33787198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential immunotoxicities of poly(ethylene glycol)- vs. poly(carboxybetaine)-coated nanoparticles.
    Elsabahy M; Li A; Zhang F; Sultan D; Liu Y; Wooley KL
    J Control Release; 2013 Dec; 172(3):641-52. PubMed ID: 24056145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternating stealth polymer coatings between administrations minimizes toxic and antibody immune responses towards nanomedicine treatment regimens.
    Li B; Chu F; Lu Q; Wang Y; Lane LA
    Acta Biomater; 2021 Feb; 121():527-540. PubMed ID: 33285326
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Subbotina J; Rouse I; Lobaskin V
    Nanoscale; 2023 Aug; 15(32):13371-13383. PubMed ID: 37530535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.